3Sugiyama M, Kodama T, Konishi K, et al. Compaction and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells[J]. Biochem Biophys Res Commun, 2000,271:688-692.
4Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3E1 cells[J]. Biochem Biophys Res Commun, 2001,280:874-877.
5Zerath E, Holy X, Noel B, et al. Effects of BMP-2 on osteoblastic cells and on skeletal growth and bone formation in unloaded rats[J]. Growth Horm IGF Res, 1998,8:141-149.
6Fromigue O, Marie P J, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta 2 interact to modulate human bone marrow stromal cell proliferation and differentiation[J]. J Cell Biochem, 1998,68:411-426.
7Hay E, Hott M, Graulet A M, et al. Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation[J]. J Cell Biochem, 1999,72: 81-89.
8Edwards C J, Hart D J, Spector T D. Oral statins and increased bone-mineral density in postmenopausal women[J] .Lancet, 2000,355: 2218-2219.
9Chung Y S, Lee M D, Lee S K, et al. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients [ J ]. J Clin Endocrinol Metab, 2000,85:1137-1142.
10Meier C R, Schlienger R G, Kraenzlin M E, et al. HMGCoA reductase inhibitors and the risk of fractures [J]. JAMA,2000,283:3205-3210.
